SR

Sumit Ramdas Hanamghar

Active Director Director DIN 10762113
DIN 10762113 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Sumit Ramdas Hanamghar

Data last updated:

Sumit Ramdas Hanamghar is a Director at Hanamghar Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Hanamghar Pharmaceuticals Private Limited reported revenue of ₹19,624 (FY 2025).

DIN 10762113
Primary Designation Director
Industry Pharma
First Appointment 30 Aug 2024
Oldest Company Age 2 yrs
Largest company Hanamghar Pharmaceuticals Private Limited · ₹19,624 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Aug 20242024₹19,624 (FY 2025)Active

Board colleagues of Sumit Ramdas Hanamghar

Directorship timeline

Open interactive timeline →
Hanamghar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sumit Ramdas Hanamghar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit Ramdas Hanamghar

Sumit Ramdas Hanamghar currently holds 1 directorship: Hanamghar Pharmaceuticals Private Limited (Director, since 30 Aug 2024, revenue ₹19,624 (FY 2025)).

Sumit Ramdas Hanamghar was first appointed on 30 Aug 2024 as Director at Hanamghar Pharmaceuticals Private Limited.

The current boards of Sumit Ramdas Hanamghar's companies include Prathamesh Charudatt Jagtap (Hanamghar Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available